US Stock MarketDetailed Quotes

CYTOF Altamira Therapeutics Ltd

Watchlist
  • 0.161
  • -0.019-10.78%
15min DelayClose Jan 8 16:00 ET
606.83KMarket Cap0.01P/E (TTM)

Altamira Therapeutics Ltd Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(FY)Dec 31, 2022
(FY)Dec 31, 2021
(FY)Dec 31, 2020
(FY)Dec 31, 2019
(FY)Dec 31, 2018
(Q4)Dec 31, 2018
(Q3)Sep 30, 2018
(Q2)Jun 30, 2018
(Q1)Mar 31, 2018
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
93.44%-614.48K
37.39%-9.37M
-169.81%-14.96M
36.00%-5.54M
35.55%-8.66M
46.07%-13.44M
71.02%-1.92M
8.71%-4.22M
69.89%-2.08M
22.86%-5.22M
Net income from continuing operations
92.60%-2.12M
-53.33%-28.61M
-98.83%-18.66M
-37.13%-9.39M
41.38%-6.84M
53.40%-11.68M
21.10%-3.72M
47.03%-3.12M
50.39%-3.01M
78.20%-1.83M
Operating gains losses
----
-293.70%-418.55K
-91.94%216.08K
531.22%2.68M
44.27%-621.6K
55.71%-1.12M
260.93%2.9M
-1,119.99%-365.45K
55.21%-408.38K
-2,128.55%-3.24M
Depreciation and amortization
----
53.51%128.23K
264.25%83.53K
-27.91%22.93K
-56.93%31.81K
-41.41%73.85K
-59.98%11.02K
-46.24%16.42K
-37.72%21.83K
-25.32%24.59K
Deferred tax
-956.60%-117.71K
-147.10%-11.14K
197.09%23.65K
87.82%-24.36K
-221.45%-200.05K
1,002.81%164.72K
2,647.28%191.4K
-13.80%-9.18K
6.85%-8.34K
-11.78%-9.15K
Other non cash items
----
930.58%1.97M
-51.88%191K
31,815.43%396.91K
-99.92%1.24K
-40.04%1.6M
-90.97%84.16K
-34.91%254.13K
26.64%573.14K
-22.82%686.17K
Change In working capital
-57.76%1.62M
1,856.48%3.84M
-42.95%196.24K
127.23%343.97K
49.71%-1.26M
-422.61%-2.51M
-11.13%-1.3M
-268.43%-1.2M
211.14%577.06K
-216.79%-579.96K
-Change in receivables
484.75%429.93K
69.97%-111.74K
-227.76%-372.08K
1,591.03%291.23K
-4.57%-19.53K
-119.50%-18.68K
-118.91%-11.39K
465.16%117.41K
-80.06%10.29K
-266.57%-134.99K
-Change in inventory
-142.60%-380.28K
197.23%892.61K
---918.08K
--0
--0
----
----
----
----
----
-Change in prepaid assets
-47.92%481.04K
165.08%923.73K
-891.62%-1.42M
309.46%179.31K
-127.94%-85.61K
-0.42%306.36K
175.02%158.01K
-120.33%-24.14K
11.11%360.33K
-349.54%-187.84K
-Change in payables and accrued expense
-48.89%1.09M
-26.53%2.13M
2,396.01%2.91M
89.07%-126.56K
58.63%-1.16M
-216.66%-2.8M
-41.79%-1.45M
-325.42%-1.3M
123.06%206.43K
-156.12%-257.12K
Cash from discontinued investing activities
Operating cash flow
93.44%-614.48K
37.39%-9.37M
-169.81%-14.96M
36.00%-5.54M
35.55%-8.66M
46.07%-13.44M
71.02%-1.92M
8.71%-4.22M
69.89%-2.08M
22.86%-5.22M
Investing cash flow
Cash flow from continuing investing activities
100.11%2.46K
39.75%-2.31M
-44.71%-3.83M
14.44%-2.65M
-67.26%-3.1M
-1,714.51%-1.85M
-28,683.06%-1.9M
207.73%69.13K
-250.65%-19.68K
0
Net PPE purchase and sale
----
----
----
----
-194.81%-65.64K
1,155.51%69.23K
96.57%-225.0417
----
----
--0
Net intangibles purchase and sale
----
36.48%-2.31M
-37.30%-3.64M
13.11%-2.65M
-58.78%-3.05M
-1,176.47%-1.92M
-2,279,752.22%-1.9M
99.55%-328.1348
----
----
Net business purchase and sale
----
--0
--0
----
----
----
----
----
----
----
Net investment purchase and sale
--2.46K
--0
---195.93K
----
----
----
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
100.11%2.46K
39.75%-2.31M
-44.71%-3.83M
14.44%-2.65M
-67.26%-3.1M
-1,714.51%-1.85M
-28,683.06%-1.9M
207.73%69.13K
-250.65%-19.68K
--0
Financing cash flow
Cash flow from continuing financing activities
-88.77%1.19M
46.57%10.6M
-62.73%7.24M
154.95%19.41M
30.78%7.61M
-31.01%5.82M
263.97%3.97M
427.31%4.96M
-7,550.19%-6.21M
-64.62%3.11M
Net issuance payments of debt
----
8,602.26%6.39M
-104.31%-75.16K
215.42%1.74M
83.96%-1.51M
-339.56%-9.42M
3.02%-1.06M
---1.31M
---5.55M
---1.5M
Net common stock issuance
--1.19M
----
----
----
----
----
----
3,887.08%7.22M
-155.92%-245.14K
-40.54%5.54M
Cash dividends paid
----
--0
--0
--0
--0
--0
--0
--0
--0
--0
Proceeds from stock option exercised by employees
----
-42.91%4.27M
-59.31%7.49M
82.03%18.4M
-42.96%10.11M
--17.72M
----
----
----
----
Net other financing activities
----
77.68%-38.29K
76.47%-171.55K
25.55%-728.94K
51.96%-979.03K
-28.22%-2.04M
89.22%-146.22K
-19,107.62%-884.67K
-2,895.09%-320.31K
-202.19%-686.88K
Cash from discontinued financing activities
Financing cash flow
-88.77%1.19M
46.57%10.6M
-62.73%7.24M
154.95%19.41M
30.78%7.61M
-31.01%5.82M
263.97%3.97M
427.31%4.96M
-7,550.19%-6.21M
-64.62%3.11M
Net cash flow
Beginning cash position
-99.44%5.89K
-91.38%1.06M
677.13%12.32M
-71.53%1.58M
-63.40%5.57M
-54.34%15.21M
-74.15%5.36M
-83.86%4.43M
-60.77%13.27M
-51.57%15.7M
Current changes in cash
154.01%578.54K
90.73%-1.07M
-203.00%-11.56M
370.68%11.22M
56.22%-4.15M
42.90%-9.47M
102.58%143.05K
113.10%811.93K
-22.08%-8.31M
-207.62%-2.12M
Effect of exchange rate changes
-102.26%-591.7089
-91.73%26.18K
286.71%316.59K
924.31%81.87K
103.05%7.99K
80.62%-261.69K
-84.97%26.48K
-207.14%-136.24K
115.09%164.51K
43.77%-316.44K
End cash Position
3,416.07%583.84K
-98.46%16.6K
-91.65%1.08M
801.72%12.89M
-73.91%1.43M
-64.36%5.48M
-64.36%5.48M
-74.15%5.36M
-83.86%4.43M
-60.77%13.27M
Free cash flow
94.74%-614.48K
37.21%-11.68M
-126.96%-18.6M
30.43%-8.19M
23.32%-11.78M
38.75%-15.36M
42.41%-3.82M
10.11%-4.22M
69.62%-2.1M
23.70%-5.22M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
Unqualified Opinion with Explanatory Notes
Unqualified Opinion
Unqualified Opinion with Explanatory Notes
Unqualified Opinion with Explanatory Notes
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2023(FY)Dec 31, 2022(FY)Dec 31, 2021(FY)Dec 31, 2020(FY)Dec 31, 2019(FY)Dec 31, 2018(Q4)Dec 31, 2018(Q3)Sep 30, 2018(Q2)Jun 30, 2018(Q1)Mar 31, 2018
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 93.44%-614.48K37.39%-9.37M-169.81%-14.96M36.00%-5.54M35.55%-8.66M46.07%-13.44M71.02%-1.92M8.71%-4.22M69.89%-2.08M22.86%-5.22M
Net income from continuing operations 92.60%-2.12M-53.33%-28.61M-98.83%-18.66M-37.13%-9.39M41.38%-6.84M53.40%-11.68M21.10%-3.72M47.03%-3.12M50.39%-3.01M78.20%-1.83M
Operating gains losses -----293.70%-418.55K-91.94%216.08K531.22%2.68M44.27%-621.6K55.71%-1.12M260.93%2.9M-1,119.99%-365.45K55.21%-408.38K-2,128.55%-3.24M
Depreciation and amortization ----53.51%128.23K264.25%83.53K-27.91%22.93K-56.93%31.81K-41.41%73.85K-59.98%11.02K-46.24%16.42K-37.72%21.83K-25.32%24.59K
Deferred tax -956.60%-117.71K-147.10%-11.14K197.09%23.65K87.82%-24.36K-221.45%-200.05K1,002.81%164.72K2,647.28%191.4K-13.80%-9.18K6.85%-8.34K-11.78%-9.15K
Other non cash items ----930.58%1.97M-51.88%191K31,815.43%396.91K-99.92%1.24K-40.04%1.6M-90.97%84.16K-34.91%254.13K26.64%573.14K-22.82%686.17K
Change In working capital -57.76%1.62M1,856.48%3.84M-42.95%196.24K127.23%343.97K49.71%-1.26M-422.61%-2.51M-11.13%-1.3M-268.43%-1.2M211.14%577.06K-216.79%-579.96K
-Change in receivables 484.75%429.93K69.97%-111.74K-227.76%-372.08K1,591.03%291.23K-4.57%-19.53K-119.50%-18.68K-118.91%-11.39K465.16%117.41K-80.06%10.29K-266.57%-134.99K
-Change in inventory -142.60%-380.28K197.23%892.61K---918.08K--0--0--------------------
-Change in prepaid assets -47.92%481.04K165.08%923.73K-891.62%-1.42M309.46%179.31K-127.94%-85.61K-0.42%306.36K175.02%158.01K-120.33%-24.14K11.11%360.33K-349.54%-187.84K
-Change in payables and accrued expense -48.89%1.09M-26.53%2.13M2,396.01%2.91M89.07%-126.56K58.63%-1.16M-216.66%-2.8M-41.79%-1.45M-325.42%-1.3M123.06%206.43K-156.12%-257.12K
Cash from discontinued investing activities
Operating cash flow 93.44%-614.48K37.39%-9.37M-169.81%-14.96M36.00%-5.54M35.55%-8.66M46.07%-13.44M71.02%-1.92M8.71%-4.22M69.89%-2.08M22.86%-5.22M
Investing cash flow
Cash flow from continuing investing activities 100.11%2.46K39.75%-2.31M-44.71%-3.83M14.44%-2.65M-67.26%-3.1M-1,714.51%-1.85M-28,683.06%-1.9M207.73%69.13K-250.65%-19.68K0
Net PPE purchase and sale -----------------194.81%-65.64K1,155.51%69.23K96.57%-225.0417----------0
Net intangibles purchase and sale ----36.48%-2.31M-37.30%-3.64M13.11%-2.65M-58.78%-3.05M-1,176.47%-1.92M-2,279,752.22%-1.9M99.55%-328.1348--------
Net business purchase and sale ------0--0----------------------------
Net investment purchase and sale --2.46K--0---195.93K----------------------------
Cash from discontinued investing activities
Investing cash flow 100.11%2.46K39.75%-2.31M-44.71%-3.83M14.44%-2.65M-67.26%-3.1M-1,714.51%-1.85M-28,683.06%-1.9M207.73%69.13K-250.65%-19.68K--0
Financing cash flow
Cash flow from continuing financing activities -88.77%1.19M46.57%10.6M-62.73%7.24M154.95%19.41M30.78%7.61M-31.01%5.82M263.97%3.97M427.31%4.96M-7,550.19%-6.21M-64.62%3.11M
Net issuance payments of debt ----8,602.26%6.39M-104.31%-75.16K215.42%1.74M83.96%-1.51M-339.56%-9.42M3.02%-1.06M---1.31M---5.55M---1.5M
Net common stock issuance --1.19M------------------------3,887.08%7.22M-155.92%-245.14K-40.54%5.54M
Cash dividends paid ------0--0--0--0--0--0--0--0--0
Proceeds from stock option exercised by employees -----42.91%4.27M-59.31%7.49M82.03%18.4M-42.96%10.11M--17.72M----------------
Net other financing activities ----77.68%-38.29K76.47%-171.55K25.55%-728.94K51.96%-979.03K-28.22%-2.04M89.22%-146.22K-19,107.62%-884.67K-2,895.09%-320.31K-202.19%-686.88K
Cash from discontinued financing activities
Financing cash flow -88.77%1.19M46.57%10.6M-62.73%7.24M154.95%19.41M30.78%7.61M-31.01%5.82M263.97%3.97M427.31%4.96M-7,550.19%-6.21M-64.62%3.11M
Net cash flow
Beginning cash position -99.44%5.89K-91.38%1.06M677.13%12.32M-71.53%1.58M-63.40%5.57M-54.34%15.21M-74.15%5.36M-83.86%4.43M-60.77%13.27M-51.57%15.7M
Current changes in cash 154.01%578.54K90.73%-1.07M-203.00%-11.56M370.68%11.22M56.22%-4.15M42.90%-9.47M102.58%143.05K113.10%811.93K-22.08%-8.31M-207.62%-2.12M
Effect of exchange rate changes -102.26%-591.7089-91.73%26.18K286.71%316.59K924.31%81.87K103.05%7.99K80.62%-261.69K-84.97%26.48K-207.14%-136.24K115.09%164.51K43.77%-316.44K
End cash Position 3,416.07%583.84K-98.46%16.6K-91.65%1.08M801.72%12.89M-73.91%1.43M-64.36%5.48M-64.36%5.48M-74.15%5.36M-83.86%4.43M-60.77%13.27M
Free cash flow 94.74%-614.48K37.21%-11.68M-126.96%-18.6M30.43%-8.19M23.32%-11.78M38.75%-15.36M42.41%-3.82M10.11%-4.22M69.62%-2.1M23.70%-5.22M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified OpinionUnqualified Opinion with Explanatory NotesUnqualified OpinionUnqualified Opinion with Explanatory NotesUnqualified Opinion with Explanatory NotesUnqualified Opinion with Explanatory Notes--------
Heat List
US
Overall
Symbol
Price
% Chg

No Data